Disruption/NN
of/IN
the/DT
human/JJ
SCL/NN
locus/NN
by/IN
"/``
illegitimate/JJ
"/''
V-(D)-J/NN
recombinase/NN
activity/NN
./.

A/DT
fusion/NN
complementary/JJ
DNA/NN
in/IN
the/DT
T/NN
cell/NN
line/NN
HSB-2/NN
elucidates/VBZ
a/DT
provocative/JJ
mechanism/NN
for/IN
the/DT
disruption/NN
of/IN
the/DT
putative/JJ
hematopoietic/JJ
transcription/NN
factor/NN
SCL/NN
./.
=====
The/DT
fusion/NN
cDNA/NN
results/VBZ
from/IN
an/DT
interstitial/JJ
deletion/NN
between/IN
a/DT
previously/RB
unknown/JJ
locus/NN
,/,
SIL/NN
(/(
SCL/NN
interrupting/NN
locus/NN
)/)
,/,
and/CC
the/DT
5'/JJ
untranslated/JJ
region/NN
of/IN
SCL/NN
./.
=====
Similar/JJ
to/TO
1/CD
;/:
14/CD
translocations/NNS
,/,
this/DT
deletion/NN
disrupts/VBZ
the/DT
SCL/NN
5'/JJ
regulatory/JJ
region/NN
./.
=====
This/DT
event/NN
is/VBZ
probably/RB
mediated/VBN
by/IN
V-(D)-J/NN
recombinase/NN
activity/NN
,/,
although/IN
neither/DT
locus/NN
is/VBZ
an/DT
immunoglobulin/NN
or/CC
a/DT
T/NN
cell/NN
receptor/NN
./.
=====
Two/CD
other/JJ
T/NN
cell/NN
lines/NNS
,/,
CEM/NN
and/CC
RPMI/NN
8402/CD
,/,
have/VBP
essentially/RB
identical/JJ
deletions/NNS
./.
=====
Thus/RB
,/,
in/IN
lymphocytes/NNS
,/,
growth-affecting/JJ
genes/NNS
other/JJ
than/IN
immune/JJ
receptors/NNS
risk/VBP
rearrangements/NNS
./.